Epidemiological Characteristics of Patients With Cutaneous Lupus Erythematosus

被引:10
作者
Aviles Izquierdo, J. A. [1 ]
Cano Martinez, N. [1 ]
Lazaro Ochaita, P. [1 ]
机构
[1] Hosp Gen Univ Gregorio Maranon, Serv Dermatol, Madrid, Spain
来源
ACTAS DERMO-SIFILIOGRAFICAS | 2014年 / 105卷 / 01期
关键词
Systemic lupus erythematosus; Cutaneous lupus erythematosus; Subacute lupus erythematosus; Epidemiology; Diagnosis; Immunology;
D O I
10.1016/j.ad.2013.09.005
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
Introduction and objectives: Lupus erythematosus is a chronic autoimmune inflammatory disease with a wide clinical spectrum and variable clinical course. Few studies have analyzed the characteristics of patients with only cutaneous lupus erythematosus (CLE). The aim of this study was to describe the epidemiological, clinical, and immunological characteristics of a series of patients diagnosed with CLE. Patients and methods: An analysis was performed of the data from all patients over 18 years of age with a diagnosis of CLE and seen between January 1, 2007 and December 31, 2011 in a tertiary hospital. Results and conclusions: One hundred-one patients were included in the study. The mean age at diagnosis was 40 years and 84% were women. Subacute forms of presentation were observed in 94% of patients. The chronic discoid forms were localized to the head and neck in 79% of cases, whereas the subacute forms were on the trunk in 97% of cases. Patients with acute forms were positive for antinuclear, anti-DNA, anti-smooth muscle, and anti-RNP (ribonucleoprotein) antibodies, whereas anti-Ro and anti-La antibodies predominated in patients with subacute forms. Seventeen patients presented more than 1 subtype of CLE. Fifteen (88%) of these patients received immunosuppressor treatment versus 44 (52%) of the other 84 patients with only 1 subtype of CLE. Patients with distinct subtypes of CLE present different clinical and immunological characteristics. Oral immunosuppressants are often needed to control the disease in a large proportion of patients with different subtypes of CLE. (C) 2013 Elsevier Espana, S.L. and AEDV. All rights reserved.
引用
收藏
页码:69 / 73
页数:5
相关论文
共 17 条
[1]
STUDIES ON CRITERIA OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY FOR THE CLASSIFICATION OF CUTANEOUS LUPUS-ERYTHEMATOSUS .1. SELECTION OF CLINICAL GROUPS AND STUDY FACTORS [J].
BEUTNER, EH ;
BLASZCZYK, M ;
JABLONSKA, S ;
CHORZELSKI, TP ;
KUMAR, V ;
WOLSKA, H .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1991, 30 (06) :411-417
[2]
Cutaneous lupus erythematosus: First multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE) [J].
Biazar, Cyrus ;
Sigges, Johanna ;
Patsinakidis, Nikolaos ;
Ruland, Vincent ;
Amler, Susanne ;
Bonsmann, Gisela ;
Kuhn, Annegret .
AUTOIMMUNITY REVIEWS, 2013, 12 (03) :444-454
[3]
The spectrum of cutaneous manifestations in lupus erythematosus - the Italian experience [J].
Cardinali, C ;
Caproni, M ;
Bernacchi, E ;
Amato, L ;
Fabbri, P .
LUPUS, 2000, 9 (06) :417-423
[4]
Determining risk factors for developing systemic lupus erythematosus in patients with discoid lupus erythematosus [J].
Chong, B. F. ;
Song, J. ;
Olsen, N. J. .
BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (01) :29-35
[5]
DISTINCTIVE CUTANEOUS SUBSETS IN THE SPECTRUM OF LUPUS-ERYTHEMATOSUS [J].
GILLIAM, JN ;
SONTHEIMER, RD .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1981, 4 (04) :471-475
[6]
hematosus, 1994, ARCH DERMATOL, V130, P1308
[7]
Jimenez S, 2005, CUTANEOUS LUPUS ERYTHEMATOSUS, P33, DOI 10.1007/3-540-26581-3_3
[8]
Kalunian KC, 1997, DUBOIS LUPUS ERYTHEM, P5
[9]
Kuhn A, 2004, AUTOIMMUN REV, V4, P66
[10]
ARA and EADV criteria for classification of systemic lupus erythematosus in patients with cutaneous lupus erythematosus [J].
Parodi, A ;
Rebora, A .
DERMATOLOGY, 1997, 194 (03) :217-220